Immune Response in HIV/AIDS Patient to First Line HAART Therapy in a Tertiary Care Centre of North India

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2015, Vol 3, Issue 9

Abstract

This study was performed in 100 patients receiving first-line highly active antiretroviral therapy (HAART) through the National AIDS Control Programme of India in May-July 2013 at ART centre PGIMS Rohtak (Haryana). The patients were followed for six month for analysing the immune response and toxicity profile of first line antiretroviral therapy. Of the 100 patients the median CD4 count of enrolled patients was 233.33±151 cells/ cumm at treatment initiation; 14% had baseline CD4 count <100 cells/ cmm. Of the 100 patients 91% were alive after 6 months. The mean CD4 count of the cohort was increased from 233.33±151 cells/cumm to 434.8 ± 217cells/cumm at six month, (P < 0.0001). Mean weight increased from 48.9 ± 10 Kg to 57 ± 10.7 Kg, Mean BMI increased from 22.2 ± 4 Kg/m2 to 25.9 ± 4 .3 Kg/m2 and Mean haemoglobin increased from 10.6 ± 2 gm% to 12.8 ± 1.2 gm%. The rise was statistically significant (P < 0.0001). The side effects of HAART were reported in 70 % of the patients. The most common toxicity reported in our study was nausea and vomiting (59 %), followed by Anemia (15 %), Hepatotoxicity (3%), and Hyper pigmenation (11 %), Neurological (8 %) Oral ulcers (10 %), Peripheral neuropathy (4%), Rash (9%). which were usually self resolving or reversed after withdrawing of the offending agents. We concluded from the study that the first line HAART is efficacious and well tolerated. Keywords: HAART, CD4 count, NACO, ZLN, ZLE, TLE

Authors and Affiliations

Dr PS Ghalaut, Dr Anubha Garg, Dr Naresh Gaur, Dr Jitender Kumar Pehlajani, Dr Arvind Chahal, Dr Isha Pahuja

Keywords

Related Articles

Psychosocial Impact of Refractive Error on Medical Health Professionals

To study the psychosocial impact (emotional, functional, social well being) of refractive error on medical health professionals and its influence on life. 200,age group of 18-25years. Index Medical College &hospital Opht...

Types of Dyslipidemia in Type 2 Diabetic Patients of Haryana Region

Abstract: Dyslipidemia is elevation of serum total cholesterol (TC), triglycerides (TGs), or both, or low high-density lipoprotein cholesterol (HDL-C) level that contributes to the development of atherosclerosis, which i...

A Study to Compare Quality of Life of Healthy children and children with Thalassaemia

Abstract: Thalassaemia is an increasingly serious public health problem especially in developing countries like India.The aim is to compare the quality of life of thalassemic patients with healthy children. This comparat...

A Near Miss Accident after Medium Intensity Earthquake in a Public Hospital

A “near miss” is an unexpected incident related to system or process failure which could have caused damage, but didn't. Near-miss provides insight into both potential failure points and weaknesses in the management syst...

Study of association of Epstein Barr virus, LMP in Hodgkin lymphoma in south India

Hodgkin lymphoma is a lymphoproliferative malignancy. Originally described by Thomas Hodgkin in 1982. It has great potential for adding years of productive life by giving curative therapy as Hodgkin lymphoma are often cu...

Download PDF file
  • EP ID EP373218
  • DOI -
  • Views 33
  • Downloads 0

How To Cite

Dr PS Ghalaut, Dr Anubha Garg, Dr Naresh Gaur, Dr Jitender Kumar Pehlajani, Dr Arvind Chahal, Dr Isha Pahuja (2015). Immune Response in HIV/AIDS Patient to First Line HAART Therapy in a Tertiary Care Centre of North India. Scholars Journal of Applied Medical Sciences, 3(9), 3325-3328. https://europub.co.uk/articles/-A-373218